Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Finished Goods (2016)

Historic Finished Goods for Integra Lifesciences Holdings (IART) over the last 7 years, with Q3 2016 value amounting to $129.4 million.

  • Integra Lifesciences Holdings' Finished Goods changed N/A to $129.4 million in Q3 2016 from the same period last year, while for Sep 2016 it was $129.4 million, marking a year-over-year change of. This contributed to the annual value of $125.9 million for FY2015, which is 1635.67% down from last year.
  • As of Q3 2016, Integra Lifesciences Holdings' Finished Goods stood at $129.4 million.
  • Integra Lifesciences Holdings' 5-year Finished Goods high stood at $150.5 million for Q4 2014, and its period low was $102.4 million during Q4 2012.
  • Over the past 5 years, Integra Lifesciences Holdings' median Finished Goods value was $125.9 million (recorded in 2015), while the average stood at $125.5 million.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Finished Goods surged by 2156.71% in 2014 and then crashed by 1635.67% in 2015.
  • Over the past 5 years, Integra Lifesciences Holdings' Finished Goods (Quarter) stood at $102.4 million in 2012, then increased by 20.88% to $123.8 million in 2013, then increased by 21.57% to $150.5 million in 2014, then fell by 16.36% to $125.9 million in 2015, then increased by 2.81% to $129.4 million in 2016.
  • Its last three reported values are $129.4 million in Q3 2016, $125.9 million for Q4 2015, and $143.9 million during Q1 2015.